<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>拇指药略 | wechat-feeds</title><link>http://MzI5MDUxNjEzNQ.favicon.privacyhide.com/favicon.ico</link><description>医药行业价值分析和热点追踪</description><managingEditor> (hellodword)</managingEditor><pubDate>Sun, 09 May 2021 13:27:55 +0800</pubDate><image><url>http://MzI5MDUxNjEzNQ.favicon.privacyhide.com/favicon.ico</url><title>拇指药略 | wechat-feeds</title><link>http://MzI5MDUxNjEzNQ.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>是谁坑了康弘药业？</title><link>https://mp.weixin.qq.com/s/-W_QBlkhGtAUBrwIku8kDg</link><description></description><content:encoded><![CDATA[是谁坑了康弘药业？]]></content:encoded><pubDate>Mon, 19 Apr 2021 20:26:09 +0800</pubDate></item><item><title>美年健康突围的三重门</title><link>https://mp.weixin.qq.com/s/9vGwzVaugmLA3VUdiPe_UA</link><description></description><content:encoded><![CDATA[美年健康突围的三重门]]></content:encoded><pubDate>Fri, 16 Apr 2021 23:04:46 +0800</pubDate></item><item><title>徐镜人和被罚了7.64亿的扬子江药业</title><link>https://mp.weixin.qq.com/s/rzmalYHcxMt7kAvHfJ4Jmw</link><description></description><content:encoded><![CDATA[徐镜人和被罚了7.64亿的扬子江药业]]></content:encoded><pubDate>Thu, 15 Apr 2021 22:02:12 +0800</pubDate></item><item><title>“透视”正大天晴</title><link>https://mp.weixin.qq.com/s/-qKr6sBgJIXAYdTggtQ9Qg</link><description></description><content:encoded><![CDATA[“透视”正大天晴]]></content:encoded><pubDate>Wed, 07 Apr 2021 23:53:36 +0800</pubDate></item><item><title>创新药企太多，猴不够用，昭衍新药的猴子竟能“死而复生”？</title><link>https://mp.weixin.qq.com/s/EsXo9K83HFCWoYpiITWsAQ</link><description></description><content:encoded><![CDATA[创新药企太多，猴不够用，昭衍新药的猴子竟能“死而复生”？]]></content:encoded><pubDate>Tue, 30 Mar 2021 21:25:12 +0800</pubDate></item><item><title>三年过去，港股31家“带字母”的生物医药上市公司长大了吗？</title><link>https://mp.weixin.qq.com/s/vI_Gu-Vk4dl2N34FLyndig</link><description></description><content:encoded><![CDATA[三年过去，港股31家“带字母”的生物医药上市公司长大了吗？]]></content:encoded><pubDate>Thu, 25 Mar 2021 23:39:38 +0800</pubDate></item><item><title>微医上市的“盲盒”游戏</title><link>https://mp.weixin.qq.com/s/YB5ix14QiL_9GayAyrz3ww</link><description></description><content:encoded><![CDATA[微医上市的“盲盒”游戏]]></content:encoded><pubDate>Wed, 24 Mar 2021 14:01:27 +0800</pubDate></item><item><title>数字化转型助力走出低谷，东阿阿胶2020财年扭亏为盈</title><link>https://mp.weixin.qq.com/s/BWs2BRdVAzPfCZnbwQwysQ</link><description></description><content:encoded><![CDATA[数字化转型助力走出低谷，东阿阿胶2020财年扭亏为盈]]></content:encoded><pubDate>Wed, 24 Mar 2021 14:01:27 +0800</pubDate></item><item><title>没了西布曲明，还有东布曲明，你确定能躲过朋友圈的“郭美美”？</title><link>https://mp.weixin.qq.com/s/mDDBISZwlgI_HA9D5Nce-g</link><description></description><content:encoded><![CDATA[没了西布曲明，还有东布曲明，你确定能躲过朋友圈的“郭美美”？]]></content:encoded><pubDate>Fri, 19 Mar 2021 23:45:30 +0800</pubDate></item><item><title>玻尿酸的秘密：成本100卖到3000，爱美客神话还能维持多久？</title><link>https://mp.weixin.qq.com/s/Huhg6JRYJbcN1EAnbIwTHg</link><description></description><content:encoded><![CDATA[玻尿酸的秘密：成本100卖到3000，爱美客神话还能维持多久？]]></content:encoded><pubDate>Tue, 02 Mar 2021 23:59:22 +0800</pubDate></item><item><title>百济神州：国内首个RANKL抑制剂“安加维”降价80%进入医保</title><link>https://mp.weixin.qq.com/s/RxDUyClwfLREigdNVx_6fg</link><description></description><content:encoded><![CDATA[百济神州：国内首个RANKL抑制剂“安加维”降价80%进入医保]]></content:encoded><pubDate>Tue, 02 Mar 2021 23:59:22 +0800</pubDate></item><item><title>赛生药业：借“新冠”的东风炒“非典”的冷饭？</title><link>https://mp.weixin.qq.com/s/cEE7xvEu2Vqc2spBhC2YPA</link><description></description><content:encoded><![CDATA[赛生药业：借“新冠”的东风炒“非典”的冷饭？]]></content:encoded><pubDate>Mon, 22 Feb 2021 11:11:39 +0800</pubDate></item></channel></rss>